If you are experiencing a medical emergency, call 911.
Given the wide popularity of GLP-1 drugs, the public now increasingly recognizes that using medication to treat obesity is as legitimate as using insulin for diabetes or a statin for high cholesterol
This augmentation in GLP-1 is indeed remarkable, and the magnitude may surpass the threshold necessary to elicit an impact on locomotion
Basdas, R., Martinez-Cereijo, J
While rare, both medications can cause serious side effects such as pancreatitis, gallbladder problems, and kidney issues
The goal is to use the right peptide, for the right patient, at the right time, for the right reason